CoChat

A Randomized Trial Comparing Colchicine and Ursodeoxycholic Acid Combination to Ursodeoxycholic Acid in Primary Biliary Cirrhosis

Open access
Poupon, R E, Huet, P M, Poupon, R, Bonnand, A, Van Nhieu, J T, Zafrani, E S · 1996 · Hepatology
Cited by 90

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The efficacy of colchicine combined with ursodeoxycholic acid (UDCA) and UDCA alone in the treatment of patients with nonadvanced primary biliary cirrhosis (PBC) was evaluated in a 2–year controlled study. Seventy–four patients with PBC who had been treated previously with UDCA (at least 8 months) but still had abnormal liver test results, especially elevated alkaline phosphatase activity, were randomized to be administered colchicine (1 mg/d, 5 days per week) (n = 37) or a placebo (n = 37). In addition, the patients were treated with UDCA (13–15 mg · kg–1 · day–1). The patients underwent clinical examination and liver tests every 6 months and upper endoscopy and liver biopsy at entry and at 2 years. Procollagen type III aminoterminal peptide (PIIINP), hyaluronic acid, and sulfobromophthalein (BSP) elimination kinetics were determined at entry and after 2 years. After 2 years of treatment, relative to UDCA, colchicine combined with UDCA did not significantly improve symptoms, laboratory findings (serum bilirubin level, alkaline phosphatase and alanine transaminase [ALT] activities, immunoglobulin [Ig] M level), serum markers of fibrosis, or histological features, except lobular inflammation. Colchicine did tend to slightly reduce the progression of esophageal varices; however, the difference was not significant. BSP elimination kinetics (45–minute retention percentage) was significantly improved when treated with colchicine. During the 2–year study, the only clinical complications were variceal bleeding in one patient administered colchicine and two administered the placebo. Two patients died from nonliver causes. One severe adverse effect (peripheral neuromyopathy) was observed in a colchicine–treated patient. In conclusion, this study suggests that colchicine appears to provide a slight advantage relative to UDCA alone in patients with nonadvanced PBC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.510240520

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 90

Metadata

Authors
Poupon, R. E., Huet, P. M., Poupon, R., Bonnand, A., Van Nhieu, J. T., & Zafrani, E. S.
Venue
Hepatology
Published
1996-11
Volume
24
Issue
5
Pages
1098-1103
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2013190926
Cited by
90
References
5
FWCI
3.67
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized Trial Comparing Colchicine and Ursodeoxycholic Acid Combination to Ursodeoxycholic Acid in Primary Biliary Cirrhosis. https://app.cochat.ai/papers/10.1002/hep.510240520
The paper
Poupon, R. E., Huet, P. M., Poupon, R., Bonnand, A., Van Nhieu, J. T., & Zafrani, E. S. (1996). A Randomized Trial Comparing Colchicine and Ursodeoxycholic Acid Combination to Ursodeoxycholic Acid in Primary Biliary Cirrhosis. Hepatology. https://doi.org/10.1002/hep.510240520

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.